Ingabe ijusi likalamula linciphisa igazi?


Umbhali: Succeeder   

 

UKUHLOLWA KWESIKHUNGO SOKUXHUMANA KWESIKHUNGO
ISICELO SOKUHLAZIYA IZINTO EZINGAKUSETSHENZISWA

 

Ezinganekwaneni zezempilo zabantu, ijusi likalamula livame ukubizwa ngokuthi “igazi elincibilikisayo lemvelo.” Abantu abaningi bakholelwa ukuthi ukuphuza ingilazi yamanzi kalamula nsuku zonke kungavimbela amahlule egazi futhi kuthuthukise ukujikeleza kwegazi. Kodwa-ke, ingabe kukhona isisekelo sesayensi salesi simangalo? Ingabe ijusi likalamula lingalincishisa ngempela igazi?

Ukuze siphendule lo mbuzo, sidinga kuqala ukucacisa incazelo yesayensi yegama elithi "igazi elincane."

Ngokwezokwelapha, izidakamizwa zokunciphisa igazi zihlukaniswe kakhulu ngezigaba ezimbili: izidakamizwa zokuvimbela ukuminyana kwegazi (njenge-warfarin ne-heparin), ezivimbela umsebenzi wezinto ezibangela ukuminyana kwegazi ukuze kuvinjelwe ukuminyana kwegazi; kanye nezidakamizwa zokuvimbela ukuminyana kwegazi (njenge-aspirin), ezivimbela i-thrombosis ngokuvimbela ukuhlangana kwama-platelet. Le mithi inemiphumela emihle yezokwelapha futhi iyindlela ebalulekile yokuvimbela nokwelapha izifo zenhliziyo nemithambo yegazi.

Izakhi eziyinhloko zejusi likalamula zifaka phakathi ama-antioxidants afana ne-vithamini C, i-citric acid, nama-flavonoid. I-Vitamin C ibamba iqhaza ekuphenduleni kwe-redox emzimbeni futhi idlala indima ekugcineni ubuqotho bezindonga zemithambo yegazi. Ama-Flavonoid aboniswe ukuthi anamandla okulwa nokuvuvukala kanye nokusebenza kwe-endothelial. Izifundo zezilwane zibonise ukuthi izingxenye ezithile ezithelweni ze-citrus zingavimbela kancane ukuhlangana kwama-platelet, kodwa amandla alo mphumela aphansi kakhulu kunalawo emithi.

Ucwaningo lwango-2012 olwanyatheliswa kuyi-American Journal of Clinical Nutrition lwaphawula ukuthi ukudla izithelo ze-citrus nsuku zonke kungahlotshaniswa nengozi encishisiwe yokuqhekeka kwegazi, kodwa lokhu okutholakele kwabangelwa kakhulu ukuthuthukiswa kokudla okuphelele kunomphumela "wokuncipha" wejusi likalamula kuphela. Eqinisweni, umphumela wokudla ekuqhekekeni kwegazi ubuthakathaka kakhulu, awukwanele neze ukuphindaphinda imiphumela yokwelapha yemithi.

Okubaluleke kakhulu, ukulinganisa ijusi likalamula nomuthi wokunciphisa igazi kungaba yingozi empilweni. Kulabo abathatha ama-anticoagulant, ukudla inani elikhulu likalamula ngokungazi kungandisa ingozi yokopha ngenxa yomphumela wokudla kanye nemithi. Abantu abaphilile abathembele kujusi likalamula ukuvimbela ukujiya kwegazi ngenkathi benganaki ukudla okulinganiselayo kanye nokuzivocavoca bangase babambezele ukuphathwa kwezempilo.

Ngokweqiniso, ijusi likalamula, njengesiphuzo esinomsoco, linezinzuzo ezithile zenhliziyo uma lidliwa ngokulinganisela. Kodwa-ke, indlela esebenza ngayo iwukuhlinzeka ngama-antioxidants kanye nokuphuza amanzi amaningi, futhi alihlobene ngqo "nokunciphisa igazi."

Uma uvimbela futhi welapha izimo ezifana ne-thrombosis, kubalulekile ukulandela iseluleko sezokwelapha, ukusebenzisa imithi ngendlela efanele, nokugcina ukudla okunempilo nendlela yokuphila—lena yindlela yesayensi yokugcina impilo yemithambo yegazi.

КОНЦЕНТРАЦИЯ СЕРВИС КОАГУЛЯЦИЯ ДИАГНОСТИКА

 

АНАЛИЗАТОР РЕАГЕНТОВ ПРИМЕНЕНИЕ

I-Beijing Succeeder Technology Inc. (ikhodi yesitoko: 688338) ibilokhu ihileleke kakhulu emkhakheni wokuxilongwa kokuqina kwegazi selokhu yasungulwa ngo-2003, futhi izibophezele ekubeni ngumholi kulo mkhakha. Indlunkulu yayo eBeijing, inethimba eliqinile le-R&D, lokukhiqiza kanye nelokuthengisa, eligxile ekusungulweni nasekusetshenzisweni kobuchwepheshe bokuxilonga i-thrombosis kanye ne-hemostasis.

Ngenxa yamandla ayo obuchwepheshe avelele, iSucceeder iwine ama-patents agunyaziwe angu-45, okuhlanganisa ama-patents okusungula angu-14, ama-patents emodeli yokusetshenziswa angu-16 kanye nama-patents okuklama angu-15. Le nkampani futhi inezitifiketi zokubhaliswa komkhiqizo wedivayisi yezokwelapha zesigaba sesi-2 ezingu-32, izitifiketi zokufaka zesigaba sesi-3, kanye nesitifiketi se-EU CE semikhiqizo engu-14, futhi iphumelele isitifiketi sesistimu yokuphatha ikhwalithi ye-ISO 13485 ukuqinisekisa ubuhle nokuzinza kwekhwalithi yomkhiqizo.

I-Succeeder ayiyona nje ibhizinisi elibalulekile le-Beijing Biomedicine Industry Leapfrog Development Project (G20), kodwa futhi yafika ngempumelelo kwi-Science and Technology Innovation Board ngo-2020, yafinyelela intuthuko eqhubekayo yenkampani. Njengamanje, inkampani yakhe inethiwekhi yokuthengisa kazwelonke ehlanganisa amakhulu ama-ejenti namahhovisi. Imikhiqizo yayo ithengiswa kahle ezingxenyeni eziningi zezwe. Iphinde yandise ngenkuthalo izimakethe zaphesheya kwezilwandle futhi ithuthukisa njalo ukuncintisana kwayo kwamazwe ngamazwe.

SF-8300

I-Analyzer ye-Coagulation Ezenzakalelayo Ngokugcwele

SF-9200

I-Analyzer ye-Coagulation Ezenzakalelayo Ngokugcwele

SF-8200

I-Analyzer ye-Coagulation Ezenzakalelayo Ngokugcwele

SF-8100

I-Analyzer ye-Coagulation Ezenzakalelayo Ngokugcwele

SF-8050

I-Analyzer ye-Coagulation Ezenzakalelayo Ngokugcwele

SF-400

I-Semi Automated Coagulation Analyzer